Reven Holdings announces first patient dosed in clinical trial evaluating RJX for high-risk COVID-19

Reven Holdings announces first patient dosed in clinical trial evaluating RJX for high-risk COVID-19

WESTMINSTER -- Reven Holdings, Inc. today announced the first patient has been dosed in the Phase I/II trial of RJX in high-risk COVID-19 patients ( ClinicalTrials.gov Identifier: NCT04708340; ... Read More

Thursday April 29, 2021 0 comments Tags: Westminster, Reven Holdings, COVID-19, Fatih Uckun, Peter Lange, Michael Volk, Brian Denomme

Ampio: Ampion reduces all-cause mortality in COVID-19 respiratory distress by nearly 80%

Ampio: Ampion reduces all-cause mortality in COVID-19 respiratory distress by nearly 80%

ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced positive results in its AP-014 Phase I clinical trial utilizing inhaled Ampion in treating respiratory distress in patients as a... Read More

Wednesday April 28, 2021 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19, Michael Macaluso

Ampio study: Ampion inhibits key inflammatory pathway in COVID-19 and lupus nephritis

Ampio study: Ampion inhibits key inflammatory pathway in COVID-19 and lupus nephritis

ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced results of a pre-clinical study demonstrating Ampion inhibits an important pro-inflammatory pathway in the types of immune cells... Read More

Friday April 9, 2021 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19, lupus nephritis, Dr. David Bar-Or

CU: Carbon dioxide levels reflect COVID-19 risk

CU: Carbon dioxide levels reflect COVID-19 risk

BOULDER -- Tracking carbon dioxide levels indoors is an inexpensive and powerful way to monitor the risk of people getting COVID-19, according to new research from the Cooperative Institute for... Read More

Friday April 9, 2021 0 comments Tags: Boulder, CU Boulder, COVID-19, Zhe Peng

Ampio Pharmaceuticals details early positive results for inhaled Ampion in COVID-19 distress

Ampio Pharmaceuticals details early positive results for inhaled Ampion in COVID-19 distress

ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) revealed preliminary positive results in its AP-014 Phase I clinical trial utilizing inhaled Ampion in treating respiratory distress in... Read More

Wednesday March 17, 2021 0 comments Tags: Englewood, Ampio Pharmaceuticals, Inhaled Ampion, COVID-19, Michael Macaluso

Everside Health approved to administer COVID vaccine in 22 states, 10 more states pending

Everside Health approved to administer COVID vaccine in 22 states, 10 more states pending

DENVER -- Everside Health (formerly Paladina Health, Activate Healthcare and Healthstat), announced it has been approved to administer the COVID-19 vaccine in 22 states. With pending approval in... Read More

Monday March 1, 2021 0 comments Tags: Denver, Everside Health, COVID-19, Chris Miller

Hach and LuminUltra partner to deliver first rapid test for SARS-CoV-2 in wastewater

Hach and LuminUltra partner to deliver first rapid test for SARS-CoV-2 in wastewater

LOVELAND -- Hach , a leader in water analysis, and Canada-based LuminUltra , a leader in biological diagnostic testing, have partnered to offer the world's first rapid, on-site testing solution for... Read More

Friday February 26, 2021 0 comments Tags: Loveland, Hach, LuminUltra, James Harbridge, Pat Whalen, COVID-19

CSU vaccine research advances to develop coronavirus vaccine for next pandemic

CSU vaccine research advances to develop coronavirus vaccine for next pandemic

FORT COLLINS -- As scientists at Colorado State University continue their research on four coronavirus vaccine candidates, investigators are developing a plan to collaborate with scientists at other... Read More

Wednesday February 24, 2021 0 comments Tags: Fort Collins, CSU, SolaVAX, Ray Goodrich, COVID-19